Structure Therapeutics Inc. (GPCR)

Structure Therapeutics Inc. (GPCR) is a healthcare company (biotechnology) based in the United States. The share price is $18.22, down 1.88% on the day, which values the company at $1.3B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$18.22−1.88% today
Market value
$1.3B
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Structure Therapeutics Inc. in more detail

GPCR trades at -7.3× next year's expected earnings.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Debt is growing faster than cash flow.

1 of the superinvestors tracked here hold GPCR, including Julian and Felix Baker (0.4% of the portfolio).

Superinvestors holding GPCR

1 of the investors tracked here report a position in their latest 13F filing.

Structure Therapeutics Inc. (GPCR): questions and answers

What is Structure Therapeutics Inc.'s market cap?

Structure Therapeutics Inc. is valued at $1.3B at a share price of $18.22.

Does GPCR pay a dividend?

Structure Therapeutics Inc. does not currently pay a regular dividend.

Which famous investors own GPCR?

In their latest quarterly filings, Julian and Felix Baker (0.4% of the portfolio) hold GPCR. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Structure Therapeutics Inc. (GPCR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/GPCR

Underlying data: Yahoo Finance; company filings with the SEC.